PAVMPAVmed Inc.

Nasdaq pavmed.com


$ 1.92 $ -0.20 (-9.43 %)    

Monday, 13-May-2024 14:09:17 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 1.92
$ 2.17
$ 0.00 x 0
$ 0.00 x 0
$ 1.90 - $ 2.17
$ 1.60 - $ 9.00
51,590
na
16.69M
$ 1.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 04-06-2022 12-31-2021 10-K
11 11-22-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-28-2020 03-31-2020 10-Q
18 04-14-2020 12-31-2019 10-K
19 11-19-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-21-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-22-2017 03-31-2017 10-Q
30 02-16-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 04-11-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-late-monday-pavmed-q1-2024-adj-eps-099-beats-167-estimate-sales-1010m-miss-1053m-estimate

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.99) per share which beat the analyst consensus estimate of $(1.67) by 40....

Core News & Articles

EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early preca...

 why-doma-holdings-shares-are-trading-higher-by-around-34-here-are-20-stocks-moving-premarket

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...

 why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

Core News & Articles

Lucid Diagnostics had cash and cash equivalents of $18.9 million as of December 31, 2023, compared to $22.5 million as of Decem...

 preview-pavmeds-earnings
Preview: PAVmed's Earnings
03/25/2024 15:01:13

Core News & Articles

Prospective VA screening study demonstrates excellent EsoGuard sensitivity of 92.9% and negative predictive value of 98.6% comp...

 why-richardson-electronics-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket

Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted wea...

 pavmed--on-jan-7-got-notification-letter-from-nasdaq-that-co-regained-compliance-with-1-minimum-bid-price-requirement-for-continued-listing

-SEC Filing

Core News & Articles

 Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical ...

Core News & Articles

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common...

Core News & Articles

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION